Mr. Gonce joined Mallinckrodt in 2019, leading business development, licensing, and commercial strategy for the Specialty Generics business. In this role, he has responsibility for driving inorganic growth and partnerships across finished dose, APIs, and contract manufacturing.
Prior to joining Specialty Generics, Mr. Gonce led operations strategy for Mundipharma, driving cost reductions across the Purdue and Mundipharma network. Previously, he worked for McKinsey & Co. serving both brand and generic pharmaceutical companies as leader of the Pharmaceutical and Medical Products Manufacturing practice. At McKinsey, he led engagements in corporate strategy, M&A, and manufacturing, quality, and supply chain transformations in 20+ pharmaceutical plants across four continents. He also worked at Hospira, now Pfizer Hospital US, coordinating responses to and remediation of FDA warning letters.
Mr. Gonce has an MBA from the University of Virginia, and a Master and Bachelors in Engineering from Duke University. He currently resides in Raleigh, NC, near our acetaminophen operations.